课题基金 / 基金详情

Quantification of protein dynamics driving the circadian clock

Quantification of protein dynamics driving the circadian clock
驱动生物钟的蛋白质动力学的量化
批准号:
BB/P017347/1
负责人:
Andrew Loudon
金额:
$77.78万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

Andrew Loudon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Circadian clocks are essential to life on our rotating planet, and in all living organisms drive 24h patterns of physiology and behaviour that adapt them to the regular changes of the light:dark cycle. The past 20 years has witnessed a revolution in our understanding of the genetic mechanisms driving the circadian clock in a wide range of organisms, and this has led to a new understanding of how a small number of core "clock genes" regulate cellular pace-making. In contrast to our new genetic understanding, we know almost nothing of how the key proteins that are encoded by these genes actually behave in order to assemble a daily timekeeper. This ignorance is because we have lacked the essential technological tools to study how these proteins move around the cell in time and space. Also, we have been unable to measure the absolute concentration of clock proteins at different phases of the circadian cycle: we know the proteins appear and disappear on a daily basis, but not how they move around the cell, nor their concentrations, individually and one relative to another, across 24 h. This is a really big gap in knowledge, since we do not know which proteins are rate-limiting, how they interact with each other and importantly, what happens to these proteins in cells in which genetic mutations lead to profound changes in the pace of the core clockwork. This is important knowledge to obtain as in modern life many people are confronted with significant challenges to their circadian clock, leading to abnormal sleep and metabolic side effects. New chrono-pharmaceutical approaches, timing drug delivery to work with the body's clockwork, are one way to address these issues, but to do so we need to understand the clock mechanism. Indeed, earlier work by our laboratory has already made significant advances in the use of these approaches in inflammatory disease. In this project, we build on a recent study in which we used cutting-edge microscopic techniques to measured the dynamic changes in a core clock protein (PER2) in real-time over the circadian cycle in single cells. Now, we propose to use a new efficient method of gene editing to attach fluorescent molecules to several key clock genes. These molecules emit light at a specific wavelength, so by using different variants attached to the 5 or so key clock proteins, we can track several clock proteins simultaneously in individual cells. Other methods will allow us to estimate when these proteins join to form a functional complex (i.e. interact) and also estimate their concentration. We will then study their behaviour in a critical pacemaking structure in the brain called the suprachiasmatic nucleus (SCN). The SCN co-ordinates and synchronises multiple body rhythms in major organs with the sleep/wake cycle, and is crucial for normal health. We will extend these studies to other cells and tissues, including fibroblasts (a common cell type in all body organs). We will apply drugs and environmental stimuli such as temperature cycles to cells to manipulate their clocks, and monitor the resulting behaviour of the clock proteins in real-time. From this, we shall gain important new insight into the central mechanisms controlling the circadian pacemaker. Finally, our proposal will generate for the field of circadian timing an un-paralleled resource base, leading to a transformation in quantitative biology in which we will be able to use mathematical modelling to predict how the clock will behave in response to environmental disruption, disease etc. This is essential knowledge, as it will guide future developments in the field of chronopharmacology.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1073/pnas.2113845119
发表时间: 2022-01-25
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Smyllie NJ, Bagnall J, Koch AA, Niranjan D, Polidarova L, Chesham JE, Chin JW, Partch CL, Loudon ASI, Hastings MH]
通讯作者: Hastings MH
DOI: 10.1038/s41467-017-00462-2
发表时间: 2017-09-12
期刊: Nature communications
影响因子: 16.6
作者: [West AC, Smith L, Ray DW, Loudon ASI, Brown TM, Bechtold DA]
通讯作者: Bechtold DA
DOI: 10.1073/pnas.2203563119
发表时间: 2022-08-23
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: []
通讯作者:
DOI: 10.7554/elife.73976
发表时间: 2022-03-14
期刊: eLife
影响因子: 7.7
作者: [Koch AA, Bagnall JS, Smyllie NJ, Begley N, Adamson AD, Fribourgh JL, Spiller DG, Meng QJ, Partch CL, Strimmer K, House TA, Hastings MH, Loudon ASI]
通讯作者: Loudon ASI
Unravelling the networks that regulate seasonal rhythmicity in the epigenome
  • 批准号:
    BB/N015584/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.48万
  • 财政年份:
    2016
  • 负责人:
    Andrew Loudon
  • 依托单位:
Local and systemic circadian cues coordinately regulate innate immunity via an epigenetic circuit.
  • 批准号:
    BB/L000954/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $62.41万
  • 财政年份:
    2014
  • 负责人:
    Andrew Loudon
  • 依托单位:
Epigenetic control of seasonal timing
  • 批准号:
    BB/K003119/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.02万
  • 财政年份:
    2013
  • 负责人:
    Andrew Loudon
  • 依托单位:
Dissection of a novel molecular pathway involved in seasonal timing in a melatonin-target tissue using an experimental and systems-level approach.
  • 批准号:
    BB/G003033/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $99.43万
  • 财政年份:
    2008
  • 负责人:
    Andrew Loudon
  • 依托单位:
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: